Bradley; Stuart Edward
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bradley; Stuart Edward.The latest application filed is for "gpcr agonists".
- Bradley; Stuart Edward - Oxford GB
- Bradley; Stuart Edward - Oxfordshire GB
- Bradley, Stuart Edward - Birmingham GB
| Patent | Date |
|---|---|
| Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders Grant 8,278,442 - Bloxham , et al. October 2, 2 | 2012-10-02 |
| GPCR Agonists App 20120172358 - Bradley; Stuart Edward ; et al. | 2012-07-05 |
| G-protein coupled receptor agonists Grant 8,193,359 - Fyfe , et al. June 5, 2 | 2012-06-05 |
| Pyridine, pyrimidine and pyrazine derivatives as GPCR agonists Grant 8,173,807 - Bradley , et al. May 8, 2 | 2012-05-08 |
| Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase Grant 8,158,622 - Bradley , et al. April 17, 2 | 2012-04-17 |
| Bicyclic aryl and heteroaryl receptor modulators Grant 8,063,247 - Bloxham , et al. November 22, 2 | 2011-11-22 |
| Indole-2-carboxylic acid amides App 20110086885 - Bradley; Stuart Edward ; et al. | 2011-04-14 |
| Pyrrolopyridine-2-carboxylic acid hydrazides Grant 7,884,112 - Bradley , et al. February 8, 2 | 2011-02-08 |
| Compounds For The Treatment Of Metabolic Disorders App 20100286112 - Barba; Oscar ; et al. | 2010-11-11 |
| Bicyclic Aryl And Heteroaryl Receptor Modulators App 20100267780 - Bloxham; Jason ; et al. | 2010-10-21 |
| Bicyclic Aryl And Heteroaryl Compounds For The Treatment Of Metabolic Disorders App 20100173886 - Bloxham; Jason ; et al. | 2010-07-08 |
| Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists App 20100035897 - Bradley; Stuart Edward ; et al. | 2010-02-11 |
| Gpcr Agonists App 20090221644 - Bradley; Stuart Edward ; et al. | 2009-09-03 |
| G-protein Coupled Receptor Agonists App 20090203676 - Barba; Oscar ; et al. | 2009-08-13 |
| G-Protein Coupled Receptor Agonists App 20090099227 - Fyfe; Matthew Colin Thor ; et al. | 2009-04-16 |
| Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase App 20090023703 - Bradley; Stuart Edward ; et al. | 2009-01-22 |
| Pyrrolopyridine-2-Carboxylic Acid Hydrazides App 20080269277 - Bradley; Stuart Edward ; et al. | 2008-10-30 |
| Indole-2-Carboxylic Acid Hydrazides App 20080188472 - Bradley; Stuart Edward ; et al. | 2008-08-07 |
| Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase Grant 7,405,210 - Bradley , et al. July 29, 2 | 2008-07-29 |
| Pyrrolopyridine-2-carboxylic Acid Amide Inhibitors Of Glycogen Phosphorylase App 20070244090 - Bradley; Stuart Edward ; et al. | 2007-10-18 |
| Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase App 20050261272 - Bradley, Stuart Edward ; et al. | 2005-11-24 |
| Process for preparing resorcinol derivatives App 20050143594 - Bradley, Stuart Edward ; et al. | 2005-06-30 |
| Process for preparing resorcinol derivatives Grant 6,861,564 - Bradley , et al. March 1, 2 | 2005-03-01 |
| Process for preparing resorcinol derivatives App 20030088113 - Bradley, Stuart Edward ; et al. | 2003-05-08 |
| Process for preparing resorcinol derivatives App 20020032352 - Bradley, Stuart Edward ; et al. | 2002-03-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 